Patients’ Preferences for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

Bidur Banjara,1,2 Nabin Poudel,1 Kimberly B Garza,1 Salisa Westrick,1 Heather P Whitley,3 David Redden,4 Surachat Ngorsuraches1 1Department of Health Outcomes Research and Policy, Auburn University, Harrison College of Pharmacy, Auburn, AL, USA; 2Cytel Inc, Waltham, MA, USA; 3Department of Pharmacy...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Banjara B, Poudel N, Garza KB, Westrick S, Whitley HP, Redden D, Ngorsuraches S
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Dove Medical Press 2022-12-01
Rangatū:	Patient Preference and Adherence
Ngā marau:	diabetes discrete choice experiment patient preference second-line antihyperglycemic agents
Urunga tuihono:	https://www.dovepress.com/patients-preferences-for-sodium-glucose-cotransporter-2-inhibitors-and-peer-reviewed-fulltext-article-PPA
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!